Viewing Study NCT04394351


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-25 @ 9:54 PM
Study NCT ID: NCT04394351
Status: COMPLETED
Last Update Posted: 2025-10-27
First Post: 2020-05-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
Sponsor: Regeneron Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-09-01
Start Date Type: ACTUAL
Primary Completion Date: 2022-06-02
Primary Completion Date Type: ACTUAL
Completion Date: 2024-05-14
Completion Date Type: ACTUAL
First Submit Date: 2020-05-07
First Submit QC Date: None
Study First Post Date: 2020-05-19
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-02-23
Results First Submit QC Date: None
Results First Post Date: 2024-08-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2024-08-27
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2025-10-13
Last Update Post Date: 2025-10-27
Last Update Post Date Type: ESTIMATED